Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells

Journal of Orthopaedic Research

Volumn 31, Issue 4, 2013, Pages 608-615

  Yamamoto, Junya ^a   Maeno, Koichiro ^a   Takada, Toru ^a   Kakutani, Kenichiro ^a   Yurube, Takashi ^a   Zhang, Zhongying ^a   Hirata, Hiroaki ^a   Kurakawa, Takuto ^a   Sakai, Daisuke ^b   Mochida, Joji ^b   Doita, Minoru ^c   Kurosaka, Masahiro ^a   Nishida, Kotaro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Takatsuki   (Japan)

Author keywords

a disintegrin and metalloproteinase (ADAM) 10; Fas ligand (FasL); intervertebral disc herniation; nucleus pulposus cell; pro inflammatory cytokines

Indexed keywords

ADAM10 ENDOPEPTIDASE; FAS LIGAND; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; INTERVERTEBRAL DISK; MACROPHAGE; NUCLEUS PULPOSUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FAS LIGAND PROTEIN; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERVERTEBRAL DISC; MACROPHAGES; MEMBRANE PROTEINS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874662703     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22274     Document Type: Article

References (23)

1. Doita M, Kanatani T, Ozaki T, et al. 2001. Influence of macrophage infiltration of herniated disc tissue on the production of matrix metalloproteinases leading to disc resorption. Spine 26: 1522-1527.
2. Takada T, Nishida K, Doita M, et al. 2004. Interleukin-6 production is upregulated by interaction between disc tissue and macrophages. Spine 29: 1089-1092; discussion 1093.
3. Haro H, Crawford HC, Fingleton B, et al. 2000. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest 105: 133-141.
4. Takahashi T, Tanaka M, Inazawa J, et al. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 6: 1567-1574.
5. Griffith TS, Brunner T, Fletcher SM, et al. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192.
6. Bellgrau D, Gold D, Selawry H, et al. 1995. A Role for Cd95 ligand in preventing graft-rejection. Nature 377: 630-632.
7. Nagata S., 1999. Fas ligand-induced apoptosis. Ann Rev Genet 33: 29-55.
8. Takada T, Nishida K, Doita M, et al. 2002. Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine 27: 1526-1530.
9. Inui Y, Nishida K, Doita M, et al. 2004. Fas-ligand expression on nucleus pulposus begins in developing embryo. Spine 29: 2365-2369.
10. Park JB, Lee JK, Park EY, et al. 2008. Fas/FasL interaction of nucleus pulposus and cancer cells with the activation of caspases. Int Orthop 32: 835-840.
11. Moss ML, Bartsch JW., 2004. Therapeutic benefits from targeting of ADAM family members. Biochemistry 43: 7227-7235.
12. Blobel CP., 2005. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6: 32-43.
13. Schulte M, Reiss K, Lettau M, et al. 2007. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ 14: 1040-1049.
14. Voss M, Lettau M, Paulsen M, et al. 2008. Posttranslational regulation of Fas ligand function. Cell Commun Signal 6: 11.
15. Sakai D, Mochida J, Yamamoto Y, et al. 2004. Immortalization of human nucleus pulposus cells by a recombinant SV40 adenovirus vector: establishment of a novel cell line for the study of human nucleus pulposus cells. Spine 29: 1515-1523.
16. Yamamoto Y, Mochida J, Sakai D, et al. 2004. Upregulation of the viability of nucleus pulposus cells by bone marrow-derived stromal cells: significance of direct cell-to-cell contact in coculture system. Spine 29: 1508-1514.
17. Wuertz K, Godburn K, MacLean JJ, et al. 2009. In vivo remodeling of intervertebral discs in response to short- and long-term dynamic compression. J Orthop Res 27: 1235-1242.
18. Samartzis D, Karppinen J, Mok F, et al. 2011. A population-based study of juvenile disc degeneration and its association with Overweight and obesity, low back pain, and diminished functional status. J Bone Joint Surg Am 93A: 662-670.
19. Yoshida M, Nakamura T, Sei A, et al. 2005. Intervertebral disc cells produce tumor necrosis factor alpha, interleukin-1 beta, and monocyte chemoattractant protein-1 immediately after herniation: an experimental study using a new hernia model. Spine 30: 55-61.
20. Vudattu NK, Holler E, Ewing P, et al. 2005. Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4(+) and CD8(+) T cells against human microvascular endothelial cells. Immunology 115: 536-543.
21. Luckerath K, Kirkin V, Melzer IM, et al. 2011. Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain. Blood 117: 519-529.
22. Takada T, Nishida K, Maeno K, et al. 2012. Intervertebral disc and macrophage interaction induce mechanical hyperalgesia and cytokine production in a herniated disc model. Arthritis Rheum 64: 2601-2610.
23. Zhang Z, Kakutani K, Maeno K, et al. 2011. Expression of silent mating type information regulator 2 homolog 1 and its role in human intervertebral disc cell homeostasis. Arthritis Res Ther 13: R200.